Atlas Trials

Canakinumab in Covid-19 Cardiac Injury (The Three C Study)

Clinical trial NCT04365153 · COMPLETED

Trial details

NCT number
NCT04365153
Sponsor
The Cleveland Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19SARS-CoV 2
Start date
2020-04-24
Primary completion
2021-02-02
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.